glp 1 agonist bone density New Research on GLP-1s & Health 🦴 ​A new large-scale study has raised questions about the long-term effects of GLP-1 receptor agonists (like Ozempic and Wegovy). While these medications are revolutionary Frontiers | The Impact of

They also note that upper gastrointestinal symptoms alone should not be used to determine gastric content. In my opinion, these guidelines offer much better and clearer recommendations

However, in subjects with or without pre-existing HF symptoms, linagliptin and sitagliptin had a neutral effect

It has therefore been postulated that the administration of molecules capable of mimicking the action of GLP-1 and/or GIP could reproduce this incretin effect and thus stimulate insulin production and improve glycemic control in type 2 diabetics

doi: 10.1111/jgh.12271

The TRIUMPH-1 trial enrolled adults with a BMI of 30 or above, or a BMI of at least 27 plus a weight-related health condition